Search - tctmd.com

Displaying 61 - 80 of 197

Sort: Relevancy | Date

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Todd Neale

December 29, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

Advertisement

April 2024 Dispatch for the CV Team

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

March 2024 Dispatch for the CV Team

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Top General Cardiology and CVD Prevention News of 2023

January 2024 Dispatch for the CV Team

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

AHA Selects 2023’s Leading Cardiovascular Research

Who Benefits Most From Semaglutide and How Long Will That Take?

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

December 2023 Dispatch for the CV Team

November 2023 News Roundup

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 2023 News Roundup

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content